방사선종양학

본문글자크기
  • 2021년 01월호
    [Strahlenther Onkol.] Impact of intracavitary brachytherapy technique (2D versus 3D) on outcomes of cervical cancer: a systematic review and meta-analysis

    울산의대 / 김연주, 김영석*

  • 출처
    Strahlenther Onkol.
  • 등재일
    2020 Nov
  • 저널이슈번호
    196(11):973-982. doi: 10.1007/s00066-020-01658-0. Epub 2020 Jul 6.
  • 내용

    바로가기  >

    Abstract
    Purpose: To perform a systematic review and meta-analysis of the impact of brachytherapy (BT) technique (two-dimensional [2D] or three-dimensional image-guided [3D]) on outcomes of cervical cancer patients.

    Methods: PubMed and EMBASE databases were searched up to April 16, 2019, for studies which evaluated the effect of 3D-BT compared to 2D-BT in cervical cancer. Endpoints included cumulative incidence of severe toxicity, locoregional recurrence-free survival (LRRFS), progression-free survival (PFS), and overall survival (OS). Hazard ratios (HRs) were pooled in the meta-analysis using the random-effects model.

    Results: Six studies of eight cohorts were included in the quantitative synthesis. The pooled HR regarding toxicity was evaluated in five cohorts in three studies, and the HR of 3D-BT compared to 2D-BT was 0.54 (95% confidence interval [CI] 0.37-0.77). All six studies were included for the synthesis for LRRFS, and the pooled HR favors 3D-BT (0.61 [95% CI 0.40-0.93]). For PFS, three studies were included for analysis and 3D-BT was superior to 2D-BT (HR = 0.75 [95% CI 0.59-0.96]). Five studies were included for the pooled HR regarding OS, and pooled HR of 3D-BT compared to 2D-BT was 0.65 (95% CI 0.40-1.06).

    Conclusion: 3D-BT might reduce severe toxicity and improve LRRFS and PFS in patients with cervical cancer. 3D-BT should be considered for standard management of cervical cancer, and efforts for adopting this procedure in Korea should be pursued.

     

     

    Affiliations

    Yeon Joo Kim  1 , Hyun-Cheol Kang  2 , Young Seok Kim  3
    1 Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, 05505, Seoul, Korea (Republic of).
    2 Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea (Republic of).
    3 Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, 05505, Seoul, Korea (Republic of). ysk@amc.seoul.kr.

  • 키워드
    Intracavity; Radiotherapy; Survival; Toxicity; Uterine cervical neoplasms.
  • 덧글달기
    덧글달기
       IP : 13.59.100.42

    등록